After a year of absolute uncertainty, micro-predictions and near constant recalculations, the picture of our world and what’s next in it is becoming clearer.
If there’s one through line in this year’s report, it’s this: we are an industry working toward sustainable acceleration in the product management lifecycle. The disruption of the pandemic fueled fast-moving innovation, including untold experience cycles that showed leaders what was possible in a crisis.
So, what worked and what didn’t? What’s repeatable and important in the now normal?
There are several key themes leading us to what’s next and they start in a critically important place: new models across the spectrum from clinical development to commercialization and everything in between. Biopharma organizations around the world are validating provisional insights hard-earned in times of rapid change to identify exactly how to best achieve efficiency and effectiveness going forward.
le 7 décembre 2021 | 12:00PM EST
Subscribe now to attend this sneak preview of the Syneos Health 2022 Health Trends, where you will:
- Discover the ten key trends shaping the biopharmaceutical industry in 2022 and beyond
- Explore the new clinical and commercial models that are emerging in a climate that is incredibly challenged
- Consider the implications for sponsors, healthcare practitioners, patients and other industry stakeholders
Sign up below to receive exclusive access to the 2022 Health Trends report, newsletter and webinar.